Amylyx Pharmaceuticals, Inc. (AMLX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$144.74M | +52.0% |
| 2024 | -$301.74M | -712.4% |
| 2023 | $49.27M | +124.8% |
| 2022 | -$198.38M | -125.6% |
| 2021 | -$87.93M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$144.74M | +52.0% |
| 2024 | -$301.74M | -712.4% |
| 2023 | $49.27M | +124.8% |
| 2022 | -$198.38M | -125.6% |
| 2021 | -$87.93M | — |